Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000781371 | SCV000919350 | likely benign | not specified | 2019-08-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001427762 | SCV001630447 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2022-11-28 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001524341 | SCV001734152 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2020-06-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001524341 | SCV002739006 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-11-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004001531 | SCV004814886 | likely benign | Marfan syndrome | 2024-01-08 | criteria provided, single submitter | clinical testing |